Literature DB >> 31886682

Early substance use in the pathway from childhood attention-deficit/hyperactivity disorder (ADHD) to young adult substance use: Evidence of statistical mediation and substance specificity.

Andrea L Howard1, Traci M Kennedy2, John T Mitchell3, Margaret H Sibley2, Stephen P Hinshaw1, L Eugene Arnold4, Arunima Roy5, Annamarie Stehli6, James M Swanson6, Brooke S G Molina2.   

Abstract

This study tested whether early and developmentally atypical substance use mediates risk for adult substance use among children with attention-deficit/hyperactivity disorder (ADHD), and whether that risk is substance-specific. Participants were children with ADHD previously enrolled in a randomized controlled trial (RCT), and a demographically similar non-ADHD group, assessed at 2 through 16 years after the original RCT baseline. Self-reports of heavy drinking, marijuana use, daily smoking, and other illicit drug use were collected at follow-ups to establish atypically early and frequent use. Models estimated statistically mediated effects of childhood ADHD on adult substance use via early substance involvement, with planned comparisons to evaluate substance specificity. Results supported the mediation hypothesis, showing that childhood ADHD was associated with more frequent adult substance use via early substance involvement for marijuana, cigarettes, illicit drugs, and to a lesser extent, alcohol. Mediation was not escalated by comorbid childhood conduct disorder or oppositional defiant disorder except for early use of nonmarijuana illicit drugs. Substance-specificity in the mediational pathway was largely absent except for cigarette use, where ADHD-related early smoking most strongly predicted adult daily smoking. Findings from this study provide new evidence that atypically early substance use associated with childhood ADHD signals important cross-drug vulnerability by early adulthood, but cigarette use at a young age is especially associated with increased risk for habitual (daily) smoking specifically. Efforts to prevent, delay, or reduce substance experimentation should occur early and focus on factors relevant to multiple drugs of abuse in this at-risk population. (PsycINFO Database Record (c) 2020 APA, all rights reserved).

Entities:  

Mesh:

Year:  2019        PMID: 31886682     DOI: 10.1037/adb0000542

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  3 in total

1.  ADHD symptoms and use of anabolic androgenic steroids among male weightlifters.

Authors:  Emilie Kildal; Bjørnar Hassel; Astrid Bjørnebekk
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

Review 2.  Sex Differences in Substance Use, Prevalence, Pharmacological Therapy, and Mental Health in Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).

Authors:  Francisca Castellano-García; Ana Benito; Antonio Jovani; Alejandro Fuertes-Sáiz; María Isabel Marí-Sanmillán; Gonzalo Haro
Journal:  Brain Sci       Date:  2022-05-02

Review 3.  Tobacco and ADHD: A Role of MAO-Inhibition in Nicotine Dependence and Alleviation of ADHD Symptoms.

Authors:  Mairin Rose Taylor; Kelly Carrasco; Andres Carrasco; Arindam Basu
Journal:  Front Neurosci       Date:  2022-04-12       Impact factor: 5.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.